MedTech Funding Mandate

MedTech Funding Mandate (MTFM) 

The MedTech Funding Mandate is a commitment from the NHS Long Term Plan to get selected NICE-approved cost-saving devices, diagnostics, and digital products to NHS patients more quickly.  

The NHSE MTFM policy, launched in 2021 and last updated in 2024, mandates ICB funding for selected products, allowing healthcare providers to make these available to NHS patients. The policy outlines the payment mechanisms for the selected technologies and the support offered. See also Derby and Derbyshire CPAG Policy Specification 2025-2026  

Its implementation is supported by the Health Innovation Network (HIN). see  

• https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/the-medtech-funding-mandate/#policy 

• Health Innovation East Midlands Fast tracking innovation - MedTech Funding Mandate (MTFM) Policy 

Role of Clinical Policy Advisory Group (CPAG) 

Medical technology interventions that are outside the ICB mandate for example IPGs will require the submission and approval of a business case. 

Approved Products 

Below is a table listing all the currently approved products and links to each NICE MTG. A short summary of clinical/ patient benefit for each product can be found in Annex 1 of the NHSE MTFM policy